Report Detail

Service & Software Global Biomolecule Software Market 2026 by Company, Regions, Type and Application, Forecast to 2032

  • RnM4763777
  • |
  • 29 October, 2026
  • |
  • Global
  • |
  • 148 Pages
  • |
  • GIR
  • |
  • Service & Software

According to our (Global Info Research) latest study, the global Biomolecule Software market size was valued at US$ million in 2025 and is forecast to a readjusted size of US$ million by 2032 with a CAGR of %during review period.
It is a set of molecular biology application software package with powerful functions, beautiful interface and friendly interface.
This report is a detailed and comprehensive analysis for global Biomolecule Software market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Biomolecule Software market size and forecasts, in consumption value ($ Million), 2021-2032
Global Biomolecule Software market size and forecasts by region and country, in consumption value ($ Million), 2021-2032
Global Biomolecule Software market size and forecasts, by Type and by Application, in consumption value ($ Million), 2021-2032
Global Biomolecule Software market shares of main players, in revenue ($ Million), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Biomolecule Software
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Biomolecule Software market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Hamilton Thorne, Hermes Medical Solutions, Inc, INDICAL BIOSCIENCE, lexogen, Repligen, SCC SOFT COMPUTER, Oxford Instruments, Partek, Inc., Stilla Technologies, Vela Diagnostics, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
Biomolecule Software market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Windows
Linux
MacOS
Market segment by Application
Hospital
Clinic
Research Center
Market segment by players, this report covers
Hamilton Thorne
Hermes Medical Solutions, Inc
INDICAL BIOSCIENCE
lexogen
Repligen
SCC SOFT COMPUTER
Oxford Instruments
Partek, Inc.
Stilla Technologies
Vela Diagnostics
Vittoriobasurto
SCIEX
SoftGenetics, LLC.
Benchling
BioSistemika
CapitalBio Technology
cytena GmbH
Eppendorf SE
GenomSys
Mission Bio
Multid Analyses AB
PhenoSystems SA
Progenie Molecular
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Biomolecule Software product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Biomolecule Software, with revenue, gross margin, and global market share of Biomolecule Software from 2021 to 2026.
Chapter 3, the Biomolecule Software competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2021 to 2032.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2021 to 2026.and Biomolecule Software market forecast, by regions, by Type and by Application, with consumption value, from 2027 to 2032.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Biomolecule Software.
Chapter 13, to describe Biomolecule Software research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Classification of Biomolecule Software by Type
    • 1.3.1 Overview: Global Biomolecule Software Market Size by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 Global Biomolecule Software Consumption Value Market Share by Type in 2025
    • 1.3.3 Windows
    • 1.3.4 Linux
    • 1.3.5 MacOS
  • 1.4 Global Biomolecule Software Market by Application
    • 1.4.1 Overview: Global Biomolecule Software Market Size by Application: 2021 Versus 2025 Versus 2032
    • 1.4.2 Hospital
    • 1.4.3 Clinic
    • 1.4.4 Research Center
  • 1.5 Global Biomolecule Software Market Size & Forecast
  • 1.6 Global Biomolecule Software Market Size and Forecast by Region
    • 1.6.1 Global Biomolecule Software Market Size by Region: 2021 VS 2025 VS 2032
    • 1.6.2 Global Biomolecule Software Market Size by Region, (2021-2032)
    • 1.6.3 North America Biomolecule Software Market Size and Prospect (2021-2032)
    • 1.6.4 Europe Biomolecule Software Market Size and Prospect (2021-2032)
    • 1.6.5 Asia-Pacific Biomolecule Software Market Size and Prospect (2021-2032)
    • 1.6.6 South America Biomolecule Software Market Size and Prospect (2021-2032)
    • 1.6.7 Middle East & Africa Biomolecule Software Market Size and Prospect (2021-2032)

2 Company Profiles

  • 2.1 Hamilton Thorne
    • 2.1.1 Hamilton Thorne Details
    • 2.1.2 Hamilton Thorne Major Business
    • 2.1.3 Hamilton Thorne Biomolecule Software Product and Solutions
    • 2.1.4 Hamilton Thorne Biomolecule Software Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 Hamilton Thorne Recent Developments and Future Plans
  • 2.2 Hermes Medical Solutions, Inc
    • 2.2.1 Hermes Medical Solutions, Inc Details
    • 2.2.2 Hermes Medical Solutions, Inc Major Business
    • 2.2.3 Hermes Medical Solutions, Inc Biomolecule Software Product and Solutions
    • 2.2.4 Hermes Medical Solutions, Inc Biomolecule Software Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 Hermes Medical Solutions, Inc Recent Developments and Future Plans
  • 2.3 INDICAL BIOSCIENCE
    • 2.3.1 INDICAL BIOSCIENCE Details
    • 2.3.2 INDICAL BIOSCIENCE Major Business
    • 2.3.3 INDICAL BIOSCIENCE Biomolecule Software Product and Solutions
    • 2.3.4 INDICAL BIOSCIENCE Biomolecule Software Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 INDICAL BIOSCIENCE Recent Developments and Future Plans
  • 2.4 lexogen
    • 2.4.1 lexogen Details
    • 2.4.2 lexogen Major Business
    • 2.4.3 lexogen Biomolecule Software Product and Solutions
    • 2.4.4 lexogen Biomolecule Software Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 lexogen Recent Developments and Future Plans
  • 2.5 Repligen
    • 2.5.1 Repligen Details
    • 2.5.2 Repligen Major Business
    • 2.5.3 Repligen Biomolecule Software Product and Solutions
    • 2.5.4 Repligen Biomolecule Software Revenue, Gross Margin and Market Share (2021-2026)
    • 2.5.5 Repligen Recent Developments and Future Plans
  • 2.6 SCC SOFT COMPUTER
    • 2.6.1 SCC SOFT COMPUTER Details
    • 2.6.2 SCC SOFT COMPUTER Major Business
    • 2.6.3 SCC SOFT COMPUTER Biomolecule Software Product and Solutions
    • 2.6.4 SCC SOFT COMPUTER Biomolecule Software Revenue, Gross Margin and Market Share (2021-2026)
    • 2.6.5 SCC SOFT COMPUTER Recent Developments and Future Plans
  • 2.7 Oxford Instruments
    • 2.7.1 Oxford Instruments Details
    • 2.7.2 Oxford Instruments Major Business
    • 2.7.3 Oxford Instruments Biomolecule Software Product and Solutions
    • 2.7.4 Oxford Instruments Biomolecule Software Revenue, Gross Margin and Market Share (2021-2026)
    • 2.7.5 Oxford Instruments Recent Developments and Future Plans
  • 2.8 Partek, Inc.
    • 2.8.1 Partek, Inc. Details
    • 2.8.2 Partek, Inc. Major Business
    • 2.8.3 Partek, Inc. Biomolecule Software Product and Solutions
    • 2.8.4 Partek, Inc. Biomolecule Software Revenue, Gross Margin and Market Share (2021-2026)
    • 2.8.5 Partek, Inc. Recent Developments and Future Plans
  • 2.9 Stilla Technologies
    • 2.9.1 Stilla Technologies Details
    • 2.9.2 Stilla Technologies Major Business
    • 2.9.3 Stilla Technologies Biomolecule Software Product and Solutions
    • 2.9.4 Stilla Technologies Biomolecule Software Revenue, Gross Margin and Market Share (2021-2026)
    • 2.9.5 Stilla Technologies Recent Developments and Future Plans
  • 2.10 Vela Diagnostics
    • 2.10.1 Vela Diagnostics Details
    • 2.10.2 Vela Diagnostics Major Business
    • 2.10.3 Vela Diagnostics Biomolecule Software Product and Solutions
    • 2.10.4 Vela Diagnostics Biomolecule Software Revenue, Gross Margin and Market Share (2021-2026)
    • 2.10.5 Vela Diagnostics Recent Developments and Future Plans
  • 2.11 Vittoriobasurto
    • 2.11.1 Vittoriobasurto Details
    • 2.11.2 Vittoriobasurto Major Business
    • 2.11.3 Vittoriobasurto Biomolecule Software Product and Solutions
    • 2.11.4 Vittoriobasurto Biomolecule Software Revenue, Gross Margin and Market Share (2021-2026)
    • 2.11.5 Vittoriobasurto Recent Developments and Future Plans
  • 2.12 SCIEX
    • 2.12.1 SCIEX Details
    • 2.12.2 SCIEX Major Business
    • 2.12.3 SCIEX Biomolecule Software Product and Solutions
    • 2.12.4 SCIEX Biomolecule Software Revenue, Gross Margin and Market Share (2021-2026)
    • 2.12.5 SCIEX Recent Developments and Future Plans
  • 2.13 SoftGenetics, LLC.
    • 2.13.1 SoftGenetics, LLC. Details
    • 2.13.2 SoftGenetics, LLC. Major Business
    • 2.13.3 SoftGenetics, LLC. Biomolecule Software Product and Solutions
    • 2.13.4 SoftGenetics, LLC. Biomolecule Software Revenue, Gross Margin and Market Share (2021-2026)
    • 2.13.5 SoftGenetics, LLC. Recent Developments and Future Plans
  • 2.14 Benchling
    • 2.14.1 Benchling Details
    • 2.14.2 Benchling Major Business
    • 2.14.3 Benchling Biomolecule Software Product and Solutions
    • 2.14.4 Benchling Biomolecule Software Revenue, Gross Margin and Market Share (2021-2026)
    • 2.14.5 Benchling Recent Developments and Future Plans
  • 2.15 BioSistemika
    • 2.15.1 BioSistemika Details
    • 2.15.2 BioSistemika Major Business
    • 2.15.3 BioSistemika Biomolecule Software Product and Solutions
    • 2.15.4 BioSistemika Biomolecule Software Revenue, Gross Margin and Market Share (2021-2026)
    • 2.15.5 BioSistemika Recent Developments and Future Plans
  • 2.16 CapitalBio Technology
    • 2.16.1 CapitalBio Technology Details
    • 2.16.2 CapitalBio Technology Major Business
    • 2.16.3 CapitalBio Technology Biomolecule Software Product and Solutions
    • 2.16.4 CapitalBio Technology Biomolecule Software Revenue, Gross Margin and Market Share (2021-2026)
    • 2.16.5 CapitalBio Technology Recent Developments and Future Plans
  • 2.17 cytena GmbH
    • 2.17.1 cytena GmbH Details
    • 2.17.2 cytena GmbH Major Business
    • 2.17.3 cytena GmbH Biomolecule Software Product and Solutions
    • 2.17.4 cytena GmbH Biomolecule Software Revenue, Gross Margin and Market Share (2021-2026)
    • 2.17.5 cytena GmbH Recent Developments and Future Plans
  • 2.18 Eppendorf SE
    • 2.18.1 Eppendorf SE Details
    • 2.18.2 Eppendorf SE Major Business
    • 2.18.3 Eppendorf SE Biomolecule Software Product and Solutions
    • 2.18.4 Eppendorf SE Biomolecule Software Revenue, Gross Margin and Market Share (2021-2026)
    • 2.18.5 Eppendorf SE Recent Developments and Future Plans
  • 2.19 GenomSys
    • 2.19.1 GenomSys Details
    • 2.19.2 GenomSys Major Business
    • 2.19.3 GenomSys Biomolecule Software Product and Solutions
    • 2.19.4 GenomSys Biomolecule Software Revenue, Gross Margin and Market Share (2021-2026)
    • 2.19.5 GenomSys Recent Developments and Future Plans
  • 2.20 Mission Bio
    • 2.20.1 Mission Bio Details
    • 2.20.2 Mission Bio Major Business
    • 2.20.3 Mission Bio Biomolecule Software Product and Solutions
    • 2.20.4 Mission Bio Biomolecule Software Revenue, Gross Margin and Market Share (2021-2026)
    • 2.20.5 Mission Bio Recent Developments and Future Plans
  • 2.21 Multid Analyses AB
    • 2.21.1 Multid Analyses AB Details
    • 2.21.2 Multid Analyses AB Major Business
    • 2.21.3 Multid Analyses AB Biomolecule Software Product and Solutions
    • 2.21.4 Multid Analyses AB Biomolecule Software Revenue, Gross Margin and Market Share (2021-2026)
    • 2.21.5 Multid Analyses AB Recent Developments and Future Plans
  • 2.22 PhenoSystems SA
    • 2.22.1 PhenoSystems SA Details
    • 2.22.2 PhenoSystems SA Major Business
    • 2.22.3 PhenoSystems SA Biomolecule Software Product and Solutions
    • 2.22.4 PhenoSystems SA Biomolecule Software Revenue, Gross Margin and Market Share (2021-2026)
    • 2.22.5 PhenoSystems SA Recent Developments and Future Plans
  • 2.23 Progenie Molecular
    • 2.23.1 Progenie Molecular Details
    • 2.23.2 Progenie Molecular Major Business
    • 2.23.3 Progenie Molecular Biomolecule Software Product and Solutions
    • 2.23.4 Progenie Molecular Biomolecule Software Revenue, Gross Margin and Market Share (2021-2026)
    • 2.23.5 Progenie Molecular Recent Developments and Future Plans

3 Market Competition, by Players

  • 3.1 Global Biomolecule Software Revenue and Share by Players (2021-2026)
  • 3.2 Market Share Analysis (2025)
    • 3.2.1 Market Share of Biomolecule Software by Company Revenue
    • 3.2.2 Top 3 Biomolecule Software Players Market Share in 2025
    • 3.2.3 Top 6 Biomolecule Software Players Market Share in 2025
  • 3.3 Biomolecule Software Market: Overall Company Footprint Analysis
    • 3.3.1 Biomolecule Software Market: Region Footprint
    • 3.3.2 Biomolecule Software Market: Company Product Type Footprint
    • 3.3.3 Biomolecule Software Market: Company Product Application Footprint
  • 3.4 New Market Entrants and Barriers to Market Entry
  • 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

  • 4.1 Global Biomolecule Software Consumption Value and Market Share by Type (2021-2026)
  • 4.2 Global Biomolecule Software Market Forecast by Type (2027-2032)

5 Market Size Segment by Application

  • 5.1 Global Biomolecule Software Consumption Value Market Share by Application (2021-2026)
  • 5.2 Global Biomolecule Software Market Forecast by Application (2027-2032)

6 North America

  • 6.1 North America Biomolecule Software Consumption Value by Type (2021-2032)
  • 6.2 North America Biomolecule Software Market Size by Application (2021-2032)
  • 6.3 North America Biomolecule Software Market Size by Country
    • 6.3.1 North America Biomolecule Software Consumption Value by Country (2021-2032)
    • 6.3.2 United States Biomolecule Software Market Size and Forecast (2021-2032)
    • 6.3.3 Canada Biomolecule Software Market Size and Forecast (2021-2032)
    • 6.3.4 Mexico Biomolecule Software Market Size and Forecast (2021-2032)

7 Europe

  • 7.1 Europe Biomolecule Software Consumption Value by Type (2021-2032)
  • 7.2 Europe Biomolecule Software Consumption Value by Application (2021-2032)
  • 7.3 Europe Biomolecule Software Market Size by Country
    • 7.3.1 Europe Biomolecule Software Consumption Value by Country (2021-2032)
    • 7.3.2 Germany Biomolecule Software Market Size and Forecast (2021-2032)
    • 7.3.3 France Biomolecule Software Market Size and Forecast (2021-2032)
    • 7.3.4 United Kingdom Biomolecule Software Market Size and Forecast (2021-2032)
    • 7.3.5 Russia Biomolecule Software Market Size and Forecast (2021-2032)
    • 7.3.6 Italy Biomolecule Software Market Size and Forecast (2021-2032)

8 Asia-Pacific

  • 8.1 Asia-Pacific Biomolecule Software Consumption Value by Type (2021-2032)
  • 8.2 Asia-Pacific Biomolecule Software Consumption Value by Application (2021-2032)
  • 8.3 Asia-Pacific Biomolecule Software Market Size by Region
    • 8.3.1 Asia-Pacific Biomolecule Software Consumption Value by Region (2021-2032)
    • 8.3.2 China Biomolecule Software Market Size and Forecast (2021-2032)
    • 8.3.3 Japan Biomolecule Software Market Size and Forecast (2021-2032)
    • 8.3.4 South Korea Biomolecule Software Market Size and Forecast (2021-2032)
    • 8.3.5 India Biomolecule Software Market Size and Forecast (2021-2032)
    • 8.3.6 Southeast Asia Biomolecule Software Market Size and Forecast (2021-2032)
    • 8.3.7 Australia Biomolecule Software Market Size and Forecast (2021-2032)

9 South America

  • 9.1 South America Biomolecule Software Consumption Value by Type (2021-2032)
  • 9.2 South America Biomolecule Software Consumption Value by Application (2021-2032)
  • 9.3 South America Biomolecule Software Market Size by Country
    • 9.3.1 South America Biomolecule Software Consumption Value by Country (2021-2032)
    • 9.3.2 Brazil Biomolecule Software Market Size and Forecast (2021-2032)
    • 9.3.3 Argentina Biomolecule Software Market Size and Forecast (2021-2032)

10 Middle East & Africa

  • 10.1 Middle East & Africa Biomolecule Software Consumption Value by Type (2021-2032)
  • 10.2 Middle East & Africa Biomolecule Software Consumption Value by Application (2021-2032)
  • 10.3 Middle East & Africa Biomolecule Software Market Size by Country
    • 10.3.1 Middle East & Africa Biomolecule Software Consumption Value by Country (2021-2032)
    • 10.3.2 Turkey Biomolecule Software Market Size and Forecast (2021-2032)
    • 10.3.3 Saudi Arabia Biomolecule Software Market Size and Forecast (2021-2032)
    • 10.3.4 UAE Biomolecule Software Market Size and Forecast (2021-2032)

11 Market Dynamics

  • 11.1 Biomolecule Software Market Drivers
  • 11.2 Biomolecule Software Market Restraints
  • 11.3 Biomolecule Software Trends Analysis
  • 11.4 Porters Five Forces Analysis
    • 11.4.1 Threat of New Entrants
    • 11.4.2 Bargaining Power of Suppliers
    • 11.4.3 Bargaining Power of Buyers
    • 11.4.4 Threat of Substitutes
    • 11.4.5 Competitive Rivalry

12 Industry Chain Analysis

  • 12.1 Biomolecule Software Industry Chain
  • 12.2 Biomolecule Software Upstream Analysis
  • 12.3 Biomolecule Software Midstream Analysis
  • 12.4 Biomolecule Software Downstream Analysis

13 Research Findings and Conclusion

    14 Appendix

    • 14.1 Methodology
    • 14.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on Biomolecule Software. Industry analysis & Market Report on Biomolecule Software is a syndicated market report, published as Global Biomolecule Software Market 2026 by Company, Regions, Type and Application, Forecast to 2032. It is complete Research Study and Industry Analysis of Biomolecule Software market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    $3,480.00
    $5,220.00
    $6,960.00
    2,690.04
    4,035.06
    5,380.08
    3,239.88
    4,859.82
    6,479.76
    531,361.20
    797,041.80
    1,062,722.40
    293,712.00
    440,568.00
    587,424.00
    Credit card Logo

    Related Reports


    Reason to Buy

    Request for Sample of this report